| Comment Record |
|
Commentor |
Dr. June Wiles |
Date/Time |
2003-03-27 06:54:30 |
|
Organization |
Bio-Ion Institute |
|
Category |
Dietary Supplement Industry |
| Comments for FDA General |
| Questions |
|
1. General Comments
|
FDA already has all the enforcement powers it needs in regards to Ephedra. DSHEA as it currently stands has been adequate and appropriate for almost 10 years and should not be changed, as changing it would place an undue hardship on the American people who seek innovative and safe supplements.
|
|